|
|
| | (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Basic information |
| Product Name: | (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile | | Synonyms: | ofacitinib iMpurity;Tofacitinib Citrate Impurity;tofacitinib iMpurity;Tofacitinib Impurity 11;3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl) (methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate-one;Tofacitinib Impurity TBA;Tofacitinib Impurity 5 DiHCl;N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | | CAS: | 1640971-60-3 | | MF: | C14H20N6O | | MW: | 288.35 | | EINECS: | | | Product Categories: | ZJ;ZY | | Mol File: | 1640971-60-3.mol | ![(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Structure](CAS/20181212/GIF/1640971-60-3.gif) |
| | (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Chemical Properties |
| Melting point | 238 - 240°C | | Boiling point | 551.0±50.0 °C(Predicted) | | density | 1.249±0.06 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | pka | 6.06±0.60(Predicted) | | form | Solid | | color | White to Off-White |
| | (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Usage And Synthesis |
| Uses | Tofacitinib Citrate Impurity is derived from (3R,4R)-N,4-Dimethyl-1-benzyl-3-piperidinamine (D464895), which is a reagent used in the preparation of Janus tyrosine kinase inhibitors for the treatment of autoimmune diseases. |
| | (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Preparation Products And Raw materials |
|